Elicio Therapeutics Competitors and Similar CompaniesClear all

Elicio Therapeutics's competitors and similar companies include Core Biogenesis, Ayala Pharmaceuticals, NH TherAguix and Cullgen.

	Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.	Core Biogenesis Core Biogenesis is a biotech company developing a production platform to express recombinant proteins from plants.	Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.	NH TherAguix NH TherAguix is a clinical stage company, specializing in nanomedicine for cancer radiotherapy.	Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
Founding Date	Founding Date 2011	Founding Date 2020	Founding Date 2017	Founding Date 2015	Founding Date 2018
Type	Type Private	Type Private	Type Public	Type Private	Type Private
Tags	Tags Technology drug development oncology pharma therapy	Tags Technology biotech drug development oncology pharma therapy	Tags Healthcare Technology biotech drug development life sciences oncology pharma therapy	Tags Technology clinical research drug development oncology pharma therapy	Tags Technology biotech drug development oncology pharma therapy
Locations	Locations Cambridge, US HQ	Locations Paris, FR HQ Illkirch Graffenstaden, FR	Locations Wilmington, US HQ Rehovot, IL Wilmington, US	Locations Villeurbanne, FR HQ	Locations San Diego, US HQ Shanghai, CN Tokyo, JP
Employees	Employees 22	Employees 405% increase	Employees 29	Employees 2210% increase	Employees 4
Employee Rating	Employee Rating 5	Employee Rating N/A	Employee Rating N/A	Employee Rating N/A	Employee Rating 4
Funding
Latest funding round	Latest funding round $ 73m (over 2 years ago)	Latest funding round $ 11m (over 1 year ago)	Latest funding round N/A	Latest funding round $ 14.6m (over 4 years ago)	Latest funding round $ 16m (over 4 years ago)
Total funding raised	Total funding raised $ 150.3m	Total funding raised $ 14.1m	Total funding raised $ 47m	Total funding raised $ 14.6m	Total funding raised $ 31m